Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancers
A PD-1 inhibitor combined with SOX could significantly improve the rate of tumour regression during NAT for patients with Borrmann large type III and IV GCs.
PDF的下载单位、IP信息已删除
(2025-6-4)
cdercder
Nole
DW
无极微光
Dean
Wells
秋风
dde
学术文献互助
Kao
aaaa
v0id
共产主义战士
aajhajkahna
挖掘机
arniu2008
123
一只鱼
呵呵呵
勤恳的越泽
皖公网安备34019202002308
